In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model

Nature Medicine

Volumn 4, Issue 12, 1998, Pages 1438-1440

  Mandl, Christian W ^a   Aberle, Judith H ^a   Aberle, Stephan W ^a   Holzmann, Heidemarie ^a   Allison, Steven L ^a   Heinz, Franz X ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; VIRUS RNA;

ANIMAL MODEL; ARTICLE; BIOLISTIC TRANSFORMATION; CONTROLLED STUDY; IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TECHNIQUE; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VACCINATION; VACCINE PRODUCTION; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; BIOLISTICS; CELLS, CULTURED; CRICETINAE; ENCEPHALITIS VIRUSES, TICK-BORNE; ENZYME-LINKED IMMUNOSORBENT ASSAY; MICE; RNA, VIRAL; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VIRAL VACCINES;

ACARI; ANIMALIA; EUKARYOTA; FLAVIVIRUS; TICK-BORNE ENCEPHALITIS VIRUS;

EID: 0031787197     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/4031     Document Type: Article

References (20)

1. Ada, G. Overview of vaccines. Mol. Biotechnol. 8, 123-134 (1997).
2. Liu, M.A. Vaccine developments. Nature Med. 4, 515-519 (1998).
3. Petricciani, J.C. Regulatory philosophy and acceptability of cells for the production of biologicals. Dev. Biol. Stand. 75, 9-15 (1991).
4. nd edn. (eds. Plotkin, S.A. & Mortimer, E.A.) 889-901 (W.B. Saunders, Philadelphia, Pennsylvania, 1994).
5. Wood, D.J. & Macadam, A.J. Laboratory tests for live attenuated poliovirus vaccines. Biologicals 25, 3-15 (1997).
6. Wengler, G. et al. in Virus Taxonomy. Sixth Report of the International Committee on Taxonomy of Viruses (eds. Murphy, F.A. et al.) 415-427 (Springer-Verlag, Vienna, Austria, 1995).
7. Mandl, C.W. et al. Spontaneous and engineered deletion in the 3′' noncoding region of tick-borne encephalitis virus: Construction of highly attenuated mutants of a flavivirus. J. Virol. 72, 2132-2140 (1998).
8. Vogel, F.R. & Sarver, N. Nucleic acid vaccines. Clin. Microbiol. Rev. 8, 406-410 (1995).
9. Manickan, E., Karem, K.L. & Rouse, B.T. DNA vaccines - a modern gimmick or a boon to vaccinology? Crit. Rev. Immunol. 17, 139-154 (1997).
10. Gregoriadis, G. Genetic vaccines: strategies for optimization. Pharm. Res. 15, 661-670 (1998).
11. Donnelly, J.J., Ulmer, J.B., Shiver, J.W. & Liu, M.A. DNA vaccines. Annu. Rev. Immunol. 15, 617-648 (1997).
12. Chattergoon, M., Boyer, J. & Weiner, D.B. Genetic immunization: a new era in vaccines and immune therapeutics. FASEB J. 11, 753-763 (1997).
13. rd edn. (eds. Fields, B.N. et al.) 931-960 (Lippincott-Raven, Philadelphia, Pennsylvania, 1996).
14. Mandl, C.W., Ecker, M., Holzmann, H., Kunz, C. & Heinz, F.X. Infectious cDNA clones of tick-borne encephalitis virus European subtype prototypic strain Neudoerfl and high virulence strain Hypr. J. Gen. Virol. 78, 1049-1057 (1997).
15. Conry, R.M., LoBuglio, A.F. & Curiel, D.T. Polynucleotide-mediated immunization therapy of cancer. Semin. Oncol. 23, 135-147 (1996).
16. Nair, S.K. et al. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nature Biotechnol. 16, 364-369 (1998).
17. Qiu, P., Ziegelhoffer, P., Sun, J. & Yang, N.S. Gene gun delivery of mRNA in situ results in efficient transgene expression and genetic immunization. Gene Ther. 3, 262-268 (1996).
18. Zhou, X. et al. Self-replicating Semliki Forest virus RNA as recombinant vaccine. Vaccine 12, 1510-1514 (1994).
19. Heinz, F.X., Tuma, W., Guirakhoo, F. & Kunz, C. A model study of the use of monoclonal antibodies in capture enzyme immunoassays for antigen quantification exploiting the epitope map of tick-borne encephalitis virus. J. Biol. Standard. 14, 133-141 (1986).
20. Reed, J.L. & Muench, H. A simple method for estimating fifty percent endpoints. Am. J. Hyg. 27, 493 (1938).